Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126540111 | 12654011 | 1 | I | 20160801 | 20160816 | 20160816 | EXP | MY-ACCORD-043310 | ACCORD | PAN H, FENG DN, SONG L, SUN LR. ACUTE MYELOID LEUKEMIA FOLLOWING ETOPOSIDE THERAPY FOR EBV-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A CASE REPORT AND A BRIEF REVIEW OF THE LITERATURE. BMC PEDIATR. 2016 JUL 29;16:116. | 1.40 | YR | M | Y | 0.00000 | 20160816 | OT | CN | MY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126540111 | 12654011 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | U | 40716 | ||||||||||
| 126540111 | 12654011 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | 4800 | MG/M2 | U | 74513 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126540111 | 12654011 | 1 | Histiocytosis haematophagic |
| 126540111 | 12654011 | 2 | Histiocytosis haematophagic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126540111 | 12654011 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126540111 | 12654011 | Acute myeloid leukaemia | |
| 126540111 | 12654011 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |